Cohort study

Bojke, C., Capucci, S., Haase, C. L., Hartvig, N. V., Matthiessen, S., Morgen, C. S., et al. (2023). Association between weight loss and health care resource utilization in adults living with obesity: Evidence from a UK primary care database. Diabetes Obes Metab. http://doi.org/10.1111/dom.15256
View
Syed, U., Subramanian, A., Wraith, D. C., Lord, J. M., McGee, K., Ghokale, K., et al. (2023). Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care. Bmc Med, 21, 363. http://doi.org/10.1186/s12916-023-03049-5
View
Alkabbani, W., Shah, B. R., Zongo, A., Eurich, D. T., Alsabbagh, M. W., & Gamble, J. M. (2023). Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom. Diabetes Obes Metab. http://doi.org/10.1111/dom.15241
View
Abrahami, D., D'Andrea, E., Yin, H., Kim, S. C., Paik, J. M., Wexler, D., et al. (2023). Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom. Diabetes Obes Metab. http://doi.org/10.1111/dom.15196
View
Ayele, H. T., Reynier, P., Azoulay, L., Platt, R. W., Cabaussel, J., Benayoun, S., & Filion, K. B. (2023). The Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Am J Med. http://doi.org/10.1016/j.amjmed.2023.06.021
View
van Hulten, V., Driessen, J. H. M., Starup-Linde, J. K., Al-Mashhadi, Z. K., Viggers, R., Klungel, O. H., et al. (2023). The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. Diabetes Obes Metab. http://doi.org/10.1111/dom.15220
View
MedSci, K. K. F., Schnecke, V., Haase, C. L., Harder-Lauridsen, N. M., Rathor, N., Sommer, K., & Morgen, C. S. (2023). Weight change and risk of obesity-related complications: A retrospective population-based cohort study of a UK primary care database. Diabetes Obes Metab. http://doi.org/10.1111/dom.15154
View
Davies, M. J., Alibegovic, A. C., Jensen, A. B., Munikrishnappa, R., Nordsborg, R. B., & Braae, U. C. (2023). Real-world study of ethnic differences in glycaemic control and clinical characteristics among insulin-naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England. Diabetes Obes Metab. http://doi.org/10.1111/dom.15165
View
Warren-Gash, C., Davidson, J. A., Strongman, H., Herrett, E., Smeeth, L., Breuer, J., & Banerjee, A. (2023). Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort study. Lancet Reg Health Eur, 27, 100604. http://doi.org/10.1016/j.lanepe.2023.100604
View
Islam, N., Reynier, P., Douros, A., H. Y. Yu, O., & Filion, K. B. (2023). Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: a population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15000
View